Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Wessely, Oliver  [Clear All Filters]
Journal Article
Shankland SJ, Wessely O. Zoning in on podocytes. Kidney Int. 2022;102(5):966-968.
Esakov EL, Hale J, Richards EG, Torre-Healy L, Gullapalli K, Trivedi, iv D, Chumakova A, Wessely O, Jensen J, Lathia JD, et al. Therapeutic strategies to induce ERα in luminal breast cancer to enhance tamoxifen efficacy. Endocr Relat Cancer. 2019.
Fink EE, Sona S, Tran U, Desprez P-E, Bradley M, Qiu H, Eltemamy M, Wee A, Wolkov M, Nicolas M, et al. Single-cell and spatial mapping Identify cell types and signaling Networks in the human ureter. Dev Cell. 2022.
Shankland SJ, J Jefferson A, Wessely O. Repurposing Drugs for Diseases Associated with Podocyte Dysfunction. Kidney Int. 2023.
Wessely O, Shankland SJ. The proliferative and the antifibrotic side of PAX2 in tubular repair. Kidney Int. 2022;102(1):12-13.
Breunig M, Merkle J, Wagner M, Melzer MK, Barth TFE, Engleitner T, Krumm J, Wiedenmann S, Cohrs CM, Perkhofer L, et al. Modeling plasticity and dysplasia of pancreatic ductal organoids derived from human pluripotent stem cells. Cell Stem Cell. 2021.
Kaverina N, R Schweickart A, Chan GCher, Maggiore JC, Eng DG, Zeng Y, McKinzie SR, Perry HS, Ali A, O'Connor C, et al. Inhibiting NLRP3 signaling in aging podocytes improves their life- and health-span. Aging (Albany NY). 2023;15.